Similar articles

• How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.

  Schmidt C. Schmidt C. J Natl Cancer Inst. 2011 Jan 19;103(2):87-9. doi: 10.1093/jnci/djq557. Epub 2010 Dec 29. J Natl Cancer Inst. 2011. PMID: 21191114 No abstract available.
• ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.

  Jensen JD, Knoop A, Ewertz M, Laenkholm AV. Jensen JD, et al. Breast Cancer Res Treat. 2012 Apr;132(2):511-21. doi: 10.1007/s10549-011-1610-3. Epub 2011 Jun 11. Breast Cancer Res Treat. 2012. PMID: 21667123
• Qualitative assessment of the progesterone receptor and HER2 improves the Nottingham Prognostic Index up to 5 years after breast cancer diagnosis.

  Van Belle V, Van Calster B, Brouckaert O, Vanden Bempt I, Pintens S, Harvey V, Murray P, Naume B, Wiedswang G, Paridaens R, Moerman P, Amant F, Leunen K, Smeets A, Drijkoningen M, Wildiers H, Christiaens MR, Vergote I, Van Huffel S, Neven P. Van Belle V, et al. J Clin Oncol. 2010 Sep 20;28(27):4129-34. doi: 10.1200/JCO.2009.26.4200. Epub 2010 Aug 16. J Clin Oncol. 2010. PMID: 20713855
• Current status of HER2 testing: caught between a rock and a hard place.

  Schnitt SJ, Jacobs TW. Schnitt SJ, et al. Am J Clin Pathol. 2001 Dec;116(6):806-10. doi: 10.1309/WMN8-VTR5-DUGF-X12L. Am J Clin Pathol. 2001. PMID: 11764067 Review. No abstract available.
• Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.

  Ross JS. Ross JS. Adv Anat Pathol. 2009 Jul;16(4):204-15. doi: 10.1097/PAP.0b013e3181a9d4bf. Adv Anat Pathol. 2009. PMID: 19546609 Review.